A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients

被引:1
|
作者
Dutta, Roop [1 ]
Ryan, John G. [1 ]
Hurley, Sally [1 ]
Wylie, John [1 ,2 ]
机构
[1] St Elizabeths Med Ctr, Boston, MA USA
[2] Pfizer Inc, New York, NY USA
来源
HEART RHYTHM O2 | 2024年 / 5卷 / 05期
关键词
Atrial fibrillation; Educational intervention; Oral anticoagulation; Population health; Primary care; Quality improvement; CARE;
D O I
10.1016/j.hroo.2024.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Anticoagulation is the cornerstone of atrial fibrillation (AF) management for stroke prevention. Recently, we showed that oral anticoagulation (OAC) rates of AF patients in a large U.S. multispecialty health system are >80%. Objective The purpose of this study was to improve OAC rates in AF patients via an educational intervention targeted to primary care providers with low OAC rates. Methods Primary care clinicians were stratified by proportions of their AF patients at elevated stroke risk not taking anticoagulation medication. Clinicians with the lowest rates of anticoagulation were assigned to a target group receiving an educational program consisting of E-mail messaging summarizing anticoagulation guidelines. All other clinicians were assigned to a comparison group (CG). Data from a 6-month lead-in phase were compared with a 6-month follow-up period to determine whether the proportion of AF patients treated with OACs had changed. Results Of the 141 primary care clinicians with patients who met the inclusion criteria, 36 (25.53%) were assigned to the educational group (EG) and 105 (74.47%) to the CG. At baseline, there was a significant difference in percent of high-risk AF patients who were untreated in the EG (20.65%) compared to the high-risk patients who were untreated in the CG (13.64%; P = .001). After the educational intervention, high-risk AF patients without anticoagulation decreased in both EG (15.47%; P = .047) and CG (10.14%; P = .07), with greater absolute reduction in the EG (5.19% vs 3.50%). Conclusion A targeted education program was associated with increased anticoagulation rates for AF patients at high risk for stroke.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 50 条
  • [21] Prevention of Stroke in Patients with High-Risk Atrial Fibrillation
    Richard A. Bernstein
    Rod Passman
    Current Neurology and Neuroscience Reports, 2010, 10 : 34 - 39
  • [22] Prevention of Stroke in Patients with High-Risk Atrial Fibrillation
    Bernstein, Richard A.
    Passman, Rod
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (01) : 34 - 39
  • [23] Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation
    Heine, Gunnar H.
    Schneppe, Carolin
    Bauersachs, Rupert
    Eitel, Ingo
    Neuen, Brendon L.
    Ruff, Christian T.
    Schirmer, Stephan H.
    De Vriese, An
    CLINICAL KIDNEY JOURNAL, 2024, 17 (10)
  • [24] Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage
    Lee, So-Ryoung
    Choi, Eue-Keun
    Kwon, Soonil
    Jung, Jin-Hyung
    Han, Kyung-Do
    Cha, Myung-Jin
    Oh, Seil
    Lip, Gregory Y. H.
    STROKE, 2020, 51 (02) : 416 - 423
  • [25] Oral Anticoagulation Choice and Dosage in Very Elderly Patients with Atrial Fibrillation
    Zergioti, Martha
    Kyriakou, Melina
    Papazoglou, Andreas S.
    Kartas, Anastasios
    Moysidis, Dimitrios V.
    Samaras, Athanasios
    Karagiannidis, Efstratios
    Kamperidis, Vasileios
    Ziakas, Antonios
    Giannakoulas, George
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2025, 12 (03)
  • [26] Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
    Benz, Alexander P.
    Hohnloser, Stefan H.
    Eikelboom, John W.
    Carnicelli, Anthony P.
    Giugliano, Robert P.
    Granger, Christopher B.
    Harrington, Josephine
    Hijazi, Ziad
    Morrow, David A.
    Patel, Manesh R.
    Seiffge, David J.
    Shoamanesh, Ashkan
    Wallentin, Lars
    Yi, Qilong
    Connolly, Stuart J.
    EUROPEAN HEART JOURNAL, 2023, 44 (20) : 1807 - 1814
  • [27] Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage
    Nguyen, Nhi Y.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2020, 28 (04) : 190 - 196
  • [28] Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation
    Weimar, C.
    Benemann, J.
    Katsarava, Z.
    Weber, R.
    Diener, H. -C.
    EUROPEAN NEUROLOGY, 2008, 60 (03) : 142 - 148
  • [29] Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
    Garcia Rodriguez, Luis Alberto
    Cea Soriano, Lucia
    Munk Hald, Stine
    Hallas, Jesper
    Balabanova, Yanina
    Brobert, Gunnar
    Vora, Pareen
    Sharma, Mike
    Gaist, David
    HEART, 2021, 107 (07) : 542 - 548
  • [30] The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation
    Themistoclakis, Sakis
    Corrado, Andrea
    Marchlinski, Francis E.
    Jais, Pierre
    Zado, Erica
    Rossillo, Antonio
    Di Biase, Luigi
    Schweikert, Robert A.
    Saliba, Walid I.
    Horton, Rodney
    Mohanty, Prasant
    Patel, Dimpi
    Burkhardt, David J.
    Wazni, Oussama M.
    Bonso, Aldo
    Callans, David J.
    Haissaguerre, Michel
    Raviele, Antonio
    Natale, Andrea
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) : 735 - 743